iSpecimen Inc. Files 8-K Report

Ticker: ISPC · Form: 8-K · Filed: 2024-10-02T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, 8-k

TL;DR

iSpecimen filed an 8-K on July 25th, check for updates.

AI Summary

On July 25, 2024, iSpecimen Inc. filed an 8-K report detailing an event under Regulation FD Disclosure and Other Events. The filing does not contain specific financial figures or new material agreements but serves as a notification of events to the SEC.

Why It Matters

This filing indicates that iSpecimen Inc. has made a regulatory disclosure to the SEC, which may contain information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K notification and does not appear to disclose any immediate negative or positive material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for iSpecimen Inc.?

The primary purpose is to report events under Regulation FD Disclosure and Other Events, as of July 25, 2024.

When was the earliest event reported in this filing?

The earliest event reported was on July 25, 2024.

What is iSpecimen Inc.'s state of incorporation?

iSpecimen Inc. is incorporated in Delaware.

What is the principal executive office address for iSpecimen Inc.?

The principal executive office address is 8 Cabot Road Woburn, MA 01801.

What is the Commission File Number for iSpecimen Inc.?

The Commission File Number for iSpecimen Inc. is 001-40501.

From the Filing

0001104659-24-105451.txt : 20241002 0001104659-24-105451.hdr.sgml : 20241002 20241002161537 ACCESSION NUMBER: 0001104659-24-105451 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240725 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events FILED AS OF DATE: 20241002 DATE AS OF CHANGE: 20241002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241347529 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 tm2425411d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-07-25 2024-07-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): July 25, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 7.01. Regulation FD Disclosure.   Resignation of Chief Information Officer and Filing of Demand for Arbitration   On July 25, 2024, Benjamin Bielak, the Chief Information Officer of iSpecimen Inc., a Delaware corporation (the “ Company ”), until his resignation on July 14, 2024, initiated a Demand for Arbitration against the Company with the American Arbitration Association, pursuant to the dispute resolution provisions contained in Mr. Bielak’s employment

View on Read The Filing